Accelerating Preclinical Drug Discovery with Agentic AI: Inside Bayer’s PRINCE Multi Agent System
In the preclinical development phase of drug discovery, timely access to relevant historical data can directly impact decision-making, regulatory timelines and study design. Yet, most pharmaceutical organizations still rely on scattered systems and manual workflows to extract insights from vast volumes of structured and unstructured study data. In this webinar, we present PRINCE—Bayer’s innovative […]